SCHEMBL770067

SCHEMBL770067

CCCCCCCC(=O)OCCCO

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.77
DNM1 Q05193 1/20 0.62
NAAA Q02083 1/20 0.59
PRSS1 P07477 1/20 0.58
PRSS2 P07478 1/20 0.58
PRSS3 P35030 1/20 0.58
PAM P19021 2/20 0.58
LMNA P02545 2/20 0.56
KDM4E B2RXH2 1/20 0.56
DUSP3 P51452 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
HTR2C P28335 1/20 0.56
TSHR P16473 1/20 0.55
MAPT P10636 1/20 0.55
MGLL Q99685 1/20 0.54
ALDH1A1 P00352 1/20 0.53
PRKCA P17252 1/20 0.53
PRKCE Q02156 1/20 0.53
PRKCQ Q04759 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2532999 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL2800226 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL545425 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL3502015 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL769295 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL20348890 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL2040630 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL5608051 0.98 DGKA (0.74) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL28266709 0.98 DGKA (0.74) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL16013466 0.98 DGKA (0.74) DGKADNM1NAAAPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743053-A1 ANTIMICROBIAL SYNERGIES Symrise AG (DE) 2026-05-20 EP claimed
US-12576018-B2 Active agents for skin and hair care with sensory modifying properties SYMRISE AG (DE) 2026-03-17 US claimed
EP-4203902-B1 HAIR CARE COMPOSITION WITH A ANTIDANDRUFF EFFECT HENKEL AG & CO KGAA (DE) 2026-03-11 EP claimed
EP-4554551-B1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2026-03-11 EP claimed
WO-2026041513-A1 POLYGLYCEROL PARTIAL ESTERS OF SHORT-CHAIN CARBOXYLIC ACIDS EVONIK OPERATIONS GMBH (DE) 2026-02-26 WO claimed
EP-4618942-A1 ANTIMICROBIAL PREPARATION COMPRISING A POLYLYSINE AND PROPANEDIOL CAPRYLATE Beiersdorf AG (DE) 2025-09-24 EP claimed
US-12350357-B2 Active agents for skin and hair care with physicochemical modifying properties SYMRISE AG (DE) 2025-07-08 US claimed
WO-2025132038-A2 COSMETIC COMPOSITION COMPRISING A SYNERGISTIC ANTIMICROBIAL COMPLEX LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER (FR) 2025-06-26 WO claimed
EP-4565334-A1 SKIN AND HAIR CARE FORMULATIONS Clarity Cosmetics Inc. (US) 2025-06-11 EP claimed
CN-113518614-B Antibacterial activity of fatty acid esters and compositions thereof 西姆莱斯有限公司 2025-06-10 CN claimed
CN-113507917-A Active agent for skin and hair care having physicochemical modification property 西姆莱斯有限公司 2021-10-15 CN claimed
WO-2021007091-A2 PREBIOTIC COSMETIC COMPOSITIONS AND METHODS FOR THE PREPARATION THEREOF COSMEVIA LLC (US) 2021-01-14 WO claimed
WO-2020160741-A1 FATTY ACID ESTERS AS ANTI-MALASSEZIA AGENTS SYMRISE AG (DE) 2020-08-13 WO claimed
WO-2020160904-A1 ACTIVE AGENTS FOR SKIN AND HAIR CARE WITH PHYSICOCHEMICAL MODIFYING PROPERTIES SYMRISE AG (DE) 2020-08-13 WO claimed
WO-2020160905-A1 ANTIMICROBIAL ACTIVITY OF FATTY ACID ESTERS AND COMBINATIONS THEREOF SYMRISE AG (DE) 2020-08-13 WO claimed
WO-2020160743-A1 ACTIVE AGENTS FOR SKIN AND HAIR CARE WITH PHYSICOCHEMICAL MODIFYING PROPERTIES SYMRISE AG (DE) 2020-08-13 WO claimed
WO-2020160742-A1 ACTIVE AGENTS FOR SKIN AND HAIR CARE WITH SENSORY MODIFYING PROPERTIES SYMRISE AG (DE) 2020-08-13 WO claimed
US-10108102-B2 Fixing solution and image forming method Konica Minolta, Inc. (JP) 2018-10-23 US claimed
US-20130259550-A1 FIXING SOLUTION AND IMAGE FORMING METHOD KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2013-10-03 US claimed
EP-0359087-A2 Proteolytic perhydrolysis system and method of use for bleaching The Clorox Company (US) 1990-03-21 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12576018-B2 Active agents for skin and hair care with sensory modifying properties SCD5, SMURF1, SGMS1 DGKA 76/4885DNM1 3807/4885NAAA 1527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.